Suchergebnisse - "Tabak, Fehmi"

PubPharm (13)

1

Discontinuation of Nucleos(t)ide Analog treatment in HBeAg-Negative Non-Cirrhotic Chronic Hepatitis B Patients : Real-Life Data of 20 Years

enthalten in: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology | 2023

von Mete, B. | Kaya, S. | Kaya, A. | +8

2

Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B

enthalten in: Irish journal of medical science | 2023

von Ozdemir, Y. | Sahin Ozdemir, M. | Bayramlar, O. | +7

3

Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B

enthalten in: Journal of viral hepatitis | 2019

von van Campenhout, M. | Rijckborst, V. | Brouwer, W. | +10

4

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B

enthalten in: Alimentary pharmacology & therapeutics | 2019

von Liem, K. | van Campenhout, M. | Xie, Q. | +7

CommentIn: Aliment Pharmacol Ther. 2019 Mar;49(5):609-610. - PMID 30746775

5

Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection : ARES long-term follow-up

enthalten in: Journal of viral hepatitis | 2019

von van Campenhout, M. | Brouwer, W. | Xie, Q. | +18

6

Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2015

von Keskin, O. | Wedemeyer, H. | Tüzün, A. | +13

CommentIn: Clin Gastroenterol Hepatol. 2015 Dec;13(13):2350-2. - PMID 26254201

7

Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a

enthalten in: Journal of hepatology | 2012

von Rijckborst, V. | Hansen, B. | Ferenci, P. | +11

8

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b : relation to response and HBV genotype

enthalten in: Antiviral therapy | 2012

von Sonneveld, M. | Rijckborst, V. | Cakaloglu, Y. | +8

9

Long-term effect of interferon therapy in patients with HBeAg positive chronic hepatitis B infection

enthalten in: Digestive diseases and sciences | 2011

von Senturk, H. | Baysal, B. | Tahan, V. | +7

10

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

enthalten in: Hepatology (Baltimore, Md.) | 2010

von Rijckborst, V. | Hansen, B. | Cakaloglu, Y. | +11